Phase I Evaluation of ΔvirG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults
We conducted a phase I trial with healthy adults to evaluate WRSS1, a live, oral ΔvirG Shigella sonnei vaccine candidate. In a double-blind, randomized, dose-escalating fashion, inpatient volunteers received a single dose of either placebo (n = 7) or vaccine (n = 27) at 3 × 10(3) CFU (group 1), 3 ×...
Na minha lista:
| Publicado no: | Infect Immun |
|---|---|
| Principais autores: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127867/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11895966/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.4.2016-2021.2002 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
